Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1882 of 6351
-
Massive study aims to unlock cancer secrets in african ancestry
Knowledge-focused CompletedThe goal of this study is to develop a comprehensive characterization of genetic and molecular drivers of breast and prostate cancer in individuals of African ancestry. The study is conducted by the African Caribbean Cancer Consortium (AC3) and involves the recruitment of patient…
Sponsor: Fox Chase Cancer Center • Aim: Knowledge-focused
Last updated Aug 01, 2026 00:00 UTC
-
New RA strategy: switch drugs after 12 weeks for better control?
Disease control Recruiting nowIn rheumatoid arthritis (RA), the consensual 1st line conventional synthetic disease modifying antirheumatic drugs (csDMARD) of RA is methotrexate (MTX). In case of contra-indication or intolerance to MTX, leflunomide is an alternative. If the treatment target is not achieved wit…
Phase 3 • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New IV iron shot aims to boost low blood counts in kids who can't take pills
Disease control Recruiting nowSeveral clinical trials have been reported for ferric derisomaltose where it has been shown to be well tolerated and to improve markers of IDA. All clinical trials with ferric derisomaltose have been performed in adults, however, IDA is not specific to the adult population. In fa…
Phase 3 • Sponsor: Pharmacosmos A/S • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New pill could tame stubborn ulcerative colitis
Disease control OngoingThis is a randomized, double-blind, placebo controlled, dose-ranging Phase 2 study. The primary objective is to evaluate the efficacy and safety of SAR443122 compared to placebo in participants with moderate to severe UC. Dose selection for further clinical development will be ba…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New hope for tough liver cancers? early trial tests Two-Drug punch
Disease control OngoingTo evaluate the efficacy and safety of Cadonilimab Injection in combination with Regorafenib in the treatment of intermediate to advanced hepatocellular carcinoma that has failed at least one prior systemic therapy .
Phase 1 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New universal cell therapy shows promise for Hard-to-Treat blood cancer
Disease control Stopped earlyA Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of Universal BCMA-targeted LUCAR-B68 Cells Product in Patients With Relapsed/Refractory Multiple Myeloma
Phase 1 • Sponsor: Second Affiliated Hospital of Xi'an Jiaotong University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Experimental cell therapy targets rare Muscle-Weakening disease
Disease control CompletedMuscle-specific tyrosine kinase (MuSK) myasthenia gravis (MG) is a rare but potentially severe disease, in which patients develop pathogenic autoantibodies that specifically target the MuSK protein in the neuromuscular junction. This phase 1 study is being conducted to evaluate t…
Phase 1 • Sponsor: Cabaletta Bio • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New drug combo aims to prevent transplant complications in blood cancer patients
Disease control OngoingThis clinical trial evaluates the safety and effectiveness of adding itacitinib to cyclophosphamide and tacrolimus for the prevention of graft versus host disease (GVHD) in patients undergoing hematopoietic stem cell transplant. Itacitinib is an enzyme inhibitor that may regulate…
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Phone app aims to lift depression and boost HIV treatment in teens
Disease control OngoingThe overall goal of this study is to develop an mHealth intervention (Suubi-Mhealth) for use among Ugandan youth (14-17 years) with comorbid HIV and depression, taking into account their unique contextual, cultural, and developmental needs. This digital therapy intervention deliv…
Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New combo therapy aims to slow lung scarring in hypersensitivity pneumonitis
Disease control OngoingTo our knowledge, there is no randomized controlled trial assessing the efficacy of mycophenolate mofetil (MMF) in the treatment of HP. We aim to perform a randomized study to assess the efficacy and safety of a regimen consisting of MMF and prednisolone against a regimen consist…
Phase 4 • Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New combo tackles relapsed blood cancers after transplant
Disease control OngoingStudy to assess venetoclax + azacitidine and donor lymphocyte infusion (DLI) in patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) in relapse after allohematopoietic stem cell transplantation (AHSCT).
Phase 1/2 • Sponsor: Groupe Francophone des Myelodysplasies • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New drug combo targets genetic weakness in advanced breast cancer
Disease control PausedThis study is planned to include 80 patients with HRD positive HER2-negative advanced breast cancer to receive fluzoparib alone or fluzoparib combined with camrelizumab to observe and evaluate the efficacy and safety of fluzoparib combined with or without camrelizumab in the trea…
Phase 2 • Sponsor: wang shusen • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New Triple-Action antibody targets Hard-to-Treat blood cancers
Disease control Recruiting nowThe primary purpose of this study is to identify the recommended phase 2 dose (RP2D\[s\]) and schedule(s) to be safe for JNJ-79635322 in Part 1 (dose escalation), and to characterize the safety and tolerability of JNJ-79635322 at the RP2D(s) selected and in disease subgroups in P…
Phase 1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New study pits heat, cold, and knife against lung cancer
Disease control OngoingThis clinical study is evaluating different treatment options for patients with malignant lung tumors, including both primary lung cancer and tumors that have spread to the lungs from other parts of the body. The goal is to compare the safety, effectiveness, and quality-of-life i…
Sponsor: Aurimas Macionis • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Experimental vaccine aims to stop liver cancer from returning
Disease control OngoingThe trial is designed as a single-arm, open-label, phase I study investigating an off-the-shelf, multi-peptide-base HCC vaccine plus Montanide, combined with Durvalumab in patients with very early, early and intermediate stage of HCC. The investigational agents will be applied wi…
Phase 1 • Sponsor: National Cancer Institute, Naples • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Eye drops could replace needles for wet AMD?
Disease control CompletedThe goal of this clinical trial is to compare the safety and effect on visual acuity of three different doses of SYL1801 eye drops.
Phase 2 • Sponsor: Sylentis, S.A. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Can a spoonful of slush beat water for Post-Surgery thirst?
Symptom relief CompletedThis study was conducted to compare four different methods applied to relieve thirst-related discomfort after surgery. The study is a prospective, randomized controlled, experimental research conducted at Afyonkarahisar Health Sciences University Health Practice and Research Cent…
Sponsor: Ege University • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC
-
Can a common blood pressure pill prevent heart attacks after kidney failure in the ICU?
Disease control OngoingThe patients discharged from intensive care units (ICU) have a high incidence of cardiovascular events and mortality rate during the year following ICU discharge. Among patients admitted to the ICU, patients with acute kidney injury (AKI) display high risk of such events. The inv…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 26, 2026 14:26 UTC
-
Can combining two heart scans reveal more about clogged arteries?
Knowledge-focused CompletedThe goal of this observational study is to evaluate the complimentary information of anatomy, perfusion and viability of PET and MR. The main question\[s\] it aims to answer are: * to compare perfusion and anatomy measurements and perfusion related signals from PET and MR imagin…
Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Could a gentle brain zap boost memory in Alzheimer's and lewy body dementia?
Symptom relief Recruiting nowDouble blinded, sham-controlled, randomized trial on repeated transcranial alternating current brain stimulation (tACS) in neurodegenerative diseases. The investigators will evaluate whether a 4-times daily repeated stimulation with gamma tACS on the posterior parietal cortex can…
Sponsor: Kuopio University Hospital • Aim: Symptom relief
Last updated Jun 26, 2026 12:44 UTC